原发性干燥综合征的治疗方法。 - Suppr

Suppr

超能文献

Treatment approaches in primary Sjogren syndrome.

作者信息

Vissink Arjan, Kallenberg Cees G M, Bootsma Hendrika

出版信息

JAMA. 2010 Nov 10;304(18):2015-6; author reply 2016. doi: 10.1001/jama.2010.1582.

DOI:10.1001/jama.2010.1582

PMID:21063008

Abstract

摘要

相似文献

Treatment approaches in primary Sjogren syndrome.

JAMA. 2010 Nov 10;304(18):2015-6; author reply 2016. doi: 10.1001/jama.2010.1582.

First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.

Rheumatology (Oxford). 2014 Oct;53(10):1906-7. doi: 10.1093/rheumatology/keu161. Epub 2014 Apr 11.

Maintenance of rituximab treatment in a patient with primary Sjögren's syndrome.

Rheumatology (Oxford). 2014 Jul;53(7):1349-50. doi: 10.1093/rheumatology/ket458. Epub 2014 Jan 20.

[Sjögren's syndrome: a new approach to treatment].

Rev Med Suisse. 2012 Apr 18;8(337):843-7.

Punctal occlusion in Sjögren's syndrome needs clarification.

Nat Rev Rheumatol. 2012 Dec;8(12):752; author reply 752. doi: 10.1038/nrrheum.2012.53-c1. Epub 2012 Oct 23.

Sustained response to rituximab in a patient with Sjögren´s syndrome and severe refractory polyneuropathy.

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):808; author reply 809. Epub 2012 Oct 17.

[Efficiency of rituximab in an unusual form of primary Sjögren's syndrome: a case report].

Therapie. 2010 Nov-Dec;65(6):581-3. doi: 10.2515/therapie/2010064.

Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Nat Rev Rheumatol. 2012 May 1;8(7):399-411. doi: 10.1038/nrrheum.2012.53.

Infliximab and primary Sjogren's syndrome: comment on the article by Mariette et al.

Arthritis Rheum. 2004 Dec;50(12):4077; author reply 4077-8. doi: 10.1002/art.20803.

Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial.

Ann Rheum Dis. 2013 Jan;72(1):146-8. doi: 10.1136/annrheumdis-2012-202071. Epub 2012 Jul 31.

引用本文的文献

Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Nat Rev Rheumatol. 2012 May 1;8(7):399-411. doi: 10.1038/nrrheum.2012.53.

B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome.

J Clin Immunol. 2012 Jun;32(3):551-64. doi: 10.1007/s10875-012-9663-6. Epub 2012 Feb 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Treatment approaches in primary Sjogren syndrome.

JAMA. 2010 Nov 10;304(18):2015-6; author reply 2016. doi: 10.1001/jama.2010.1582.

First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.

Rheumatology (Oxford). 2014 Oct;53(10):1906-7. doi: 10.1093/rheumatology/keu161. Epub 2014 Apr 11.

Maintenance of rituximab treatment in a patient with primary Sjögren's syndrome.

Rheumatology (Oxford). 2014 Jul;53(7):1349-50. doi: 10.1093/rheumatology/ket458. Epub 2014 Jan 20.

[Sjögren's syndrome: a new approach to treatment].

Rev Med Suisse. 2012 Apr 18;8(337):843-7.

Punctal occlusion in Sjögren's syndrome needs clarification.

Nat Rev Rheumatol. 2012 Dec;8(12):752; author reply 752. doi: 10.1038/nrrheum.2012.53-c1. Epub 2012 Oct 23.

Sustained response to rituximab in a patient with Sjögren´s syndrome and severe refractory polyneuropathy.

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):808; author reply 809. Epub 2012 Oct 17.

[Efficiency of rituximab in an unusual form of primary Sjögren's syndrome: a case report].

Therapie. 2010 Nov-Dec;65(6):581-3. doi: 10.2515/therapie/2010064.

Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Nat Rev Rheumatol. 2012 May 1;8(7):399-411. doi: 10.1038/nrrheum.2012.53.

Infliximab and primary Sjogren's syndrome: comment on the article by Mariette et al.

Arthritis Rheum. 2004 Dec;50(12):4077; author reply 4077-8. doi: 10.1002/art.20803.

Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial.

Ann Rheum Dis. 2013 Jan;72(1):146-8. doi: 10.1136/annrheumdis-2012-202071. Epub 2012 Jul 31.

引用本文的文献

Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Nat Rev Rheumatol. 2012 May 1;8(7):399-411. doi: 10.1038/nrrheum.2012.53.

B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome.

J Clin Immunol. 2012 Jun;32(3):551-64. doi: 10.1007/s10875-012-9663-6. Epub 2012 Feb 17.